Skip to main content
Clinical Trials/NCT02637804
NCT02637804
Completed
Not Applicable

Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical Study

Coopervision, Inc.0 sites106 target enrollmentJanuary 2016
ConditionsMyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
Coopervision, Inc.
Enrollment
106
Primary Endpoint
Dryness
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Clinical evaluation of stenfilcon A compared with narafilcon A and delefilcon A

This is a total 120 subject, randomized, open label, bilateral wear, two week crossover study (each lens for 1 week) evaluating the clinical performance of stenfilcon A spherical lenses compared to narafilcon A or delefilcon A spherical lenses.

Detailed Description

The aim of this study is to evaluate the clinical performance of stenfilcon A compared with narafilcon A and delefilcon A. The study participants will be allocated to two parallel groups (Group 1 and Group 2), 60 subjects each, based on the control lenses, narafilcon A and delefilcon A spherical lenses. Study groups: Group 1: stenfilcon A vs. narafilcon A Group 2: stenfilcon A vs. delefilcon A

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
August 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A person is eligible for inclusion in the study if he/she:
  • Is over 18 years of age (inclusive)
  • Has had a self-reported visual exam in the last two years
  • Is an adapted daily disposable non-silicone hydrogel spherical contact lens wearer
  • Can achieve best corrected spectacle distance visual acuity of 20/25 or better in each eye.
  • Can achieve a distance visual acuity of 20/30 or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter.
  • Has a CL (Contact Lens) spherical prescription between - 0.75 and - 8.00 (inclusive)
  • Is willing to comply with the wear schedule.

Exclusion Criteria

  • A person will be excluded from the study if he/she:
  • Is not a habitual wearer of daily disposable non-silicone hydrogel spherical contact lenses
  • Has a CL prescription outside the range of the inclusion power range
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.
  • Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day)
  • Has contact lens best corrected distance vision worse than 20/25 in either eye
  • Presence of clinically significant (grade 2-4) anterior segment abnormalities
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear
  • Slit lamp findings that would contraindicate contact lens wear
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

Outcomes

Primary Outcomes

Dryness

Time Frame: 1 week

Subjective ratings of dryness (right after insertion, right before removal, all day long) for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. (Scale 0-10, 0=very dry, 10=no dryness at all.

Comfort

Time Frame: 1 week

Subjective ratings of comfort (right after insertion, right before removal, all day long) for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. (Scale 0-10, 0=very poor comfort, 10=very good comfort).

Vision

Time Frame: 1 week

Subjective ratings of vision (right after insertion, right before removal, all day long) for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. (Scale 0-10, 0=very poor vision, 10=very good vision).

Handling

Time Frame: 1 week

Subjective ratings of handling (lens insertion and lens removal) for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. (Scale 0-10, 0=very poor handling, 10=very good handling.

Lens Preference - Stenfilcon A/Narafilcon A (Group 1)

Time Frame: 1 week

Subjective ratings of lens preference for stenfilcon A/narafilcon A assessed at 1 week. (5 possible ratings: Prefer stenfilcon A, Little Prefer stenfilcon A, No preference, little prefer narafilcon A, prefer narafilcon A).

Lens Preference - Stenfilcon A/Delefilcon A (Group 2)

Time Frame: 1 week

Subjective ratings of lens preference for stenfilcon A/narafilcon A assessed at 1 week. (5 possible ratings: Prefer stenfilcon A, Little Prefer stenfilcon A, No preference, little prefer delefilcon A, prefer delefilcon A).

Pain and Foreign Body Sensation

Time Frame: 1 week

Subjective ratings of pain and foreign body sensation for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. Grade 0-3, 0=No sensation, 1=Slightly: sometimes felt sensation without any trouble in wearing contact lenses, 2=Mild: always felt sensation without any trouble in wearing contact lenses, 3=Heavy: could not wear contact lense due to sensation

Itching Sensation on Removal

Time Frame: 1 week

Subjective ratings of itching sensation on insertion for each lens pair assessed at 1 week. Grade 0-3, 0=No sensation, 1=Slightly: sometimes felt sensation without any trouble in wearing contact lenses, 2=Mild: always felt sensation without any trouble in wearing contact lenses, 3=Heavy: could not wear contact lense due to sensation

Red Eye Sensation

Time Frame: 1 week

Subjective ratings of red eye sensation for stenfilcon A/narafilcon A and stenfilcon A/delefilcon A assessed at 1 week. Grade 0-3, 0=No sensation, 1=Slightly: sometimes felt sensation without any trouble in wearing contact lenses, 2=Mild: always felt sensation without any trouble in wearing contact lenses, 3=Heavy: could not wear contact lense due to sensation

Secondary Outcomes

  • Lens Fit - Horizontal Centration(1 week)
  • Corneal Staining(1 week)
  • Lens Fit - Vertical Centration(1 week)
  • Lens Fit - Post-blink Movement(1 week)
  • Lens Fit Overall(1 week)
  • Conjunctival Redness(1 week)
  • Limbal Redness(1 week)
  • Corneal Neovascularization(1 week)
  • Conjunctival Staining(1 week)
  • Corneal Oedema(1 week)
  • Papillary Conjunctivitis(1 week)

Similar Trials